TABLE 1.
Characteristics of study participants enrolled in the study
| Characteristic | No. of study participants (%) or parameter valuea |
|
|---|---|---|
| LAIV (n = 97) | IIV (n = 53) | |
| Age, yr [median (range)] | 10 (3–17) | 11 (3–17) |
| Gender | ||
| Female | 48 (59) | 34 (41) |
| Male | 49 (72) | 19 (28) |
| Age category and 2013-2014 vaccine received | ||
| 3- to 8-yr-old | 40 (67)b | 20 (33) |
| IIV | 10 | 18 |
| LAIV | 8 | 0 |
| No vaccine | 21 | 2 |
| 9- to 17-yr-old | 57 (63) | 33 (37) |
| IIV | 16 | 25 |
| LAIV | 12 | 5 |
| No vaccine | 29 | 3 |
| Paired serum sample collection interval, no. of days [median (range)] | 21 (19–33) | 21 (20–29) |
a
The number of study participants or parameter value for study participants who received LAI or IIV vaccine in the 2014-2015 influenza season is given.
b
The prior season vaccine type was not determined for one participant in the 3- to 8-year-old LAIV group.